Experiment 900647

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationROWINSKY,EK: BURKE,PJ: KARP,JE: TUCKER,RW: ETTINGER,DS: DONEHOWER,RC:. (1989). PHASE I AND PHARMACODYNAMIC STUDY OF TAXOL IN REFRACTORY ACUTE LEUKEMIAS.. 49(16)
Amount utilized
Compound isolated
DiseasePATIENTS WITH REFRACTORY LEUKEMIAS WERE DOSED FOR 24 HR. TOXICITY INCLUDED MUCOSITIS, PERIPHERAL NEUROPATHY, ALOPECIA, MYALGIAS, ARTHRALGIAS, NAUSEA, VOMITING, DIARRHEA AND PULMONARY REACTION. THE RECOMMENDED PHASE II DOSE WAS 315 MG/SQ.M.
Dose amount390.0 MG
Number1
Qualitative resultWEAK ACTIVITY
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionMAXIMUM TOLERATED DOSE